GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | — | — | — | — | $6.4B | $6.5B | $7.4B | $24.4B | $30.1B | $25.5B | $11.9B | $14.6B | $10.1B | $2.1B | $1.9B | $9.9B | $2.1B | $1.7B | $1.8B | $968M |
| Inventory | $2.0B | $1.8B | $1.7B | $1.8B | $1.5B | $1.6B | $1.7B | $922M | $814M | $801M | $1.6B | $2.0B | $1.4B | $1.7B | $1.7B | $1.4B | $1.2B | $1.1B | $928M | — |
| Current assets | $13.9B | $18.3B | $19.2B | $16.1B | $14.4B | $14.8B | $16.0B | $30.3B | $35.8B | $31.8B | $19.6B | $24.8B | $17.7B | $7.0B | $6.2B | $13.9B | $5.7B | $4.8B | $4.3B | — |
| Goodwill | $8.3B | $8.3B | $8.3B | $8.3B | $8.3B | $8.3B | $8.1B | $4.1B | $4.1B | $4.2B | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B | $1.0B | $533M | $463M | — | — |
| Intangible assets | $14.0B | $17.0B | $19.9B | $26.5B | $28.9B | $33.5B | $33.1B | $13.8B | $15.7B | $17.1B | $9.0B | $10.2B | $11.1B | $11.9B | $11.7B | $1.1B | $863M | $923M | — | — |
| Total assets | $49.4B | $59.0B | $59.0B | $62.1B | $63.2B | $68.0B | $68.4B | $61.6B | $63.7B | $70.3B | $57.0B | $51.7B | $34.7B | $22.6B | $21.2B | $17.3B | $11.6B | $9.7B | $6.9B | — |
| Current liabilities | $11.0B | $11.8B | $12.0B | $11.3B | $11.2B | $11.6B | $11.4B | $9.8B | $10.6B | $11.6B | $9.2B | $9.9B | $5.8B | $6.4B | $4.2B | $2.5B | $2.5B | $1.9B | $1.2B | — |
| Long-term debt | $23.8B | $22.1B | $24.9B | $23.2B | $23.0B | $25.2B | $28.6B | $22.1B | $24.6B | $30.8B | $26.3B | $21.1B | $11.9B | $3.9B | $7.1B | $7.6B | — | — | — | — |
| Total liabilities | $37.6B | $36.4B | $39.7B | $39.4B | $42.0B | $46.9B | $50.2B | $39.0B | $42.1B | $49.8B | $37.6B | $32.6B | $18.8B | $10.8B | $11.7B | $10.4B | $5.5B | $3.2B | $2.5B | — |
| Shareholders' equity | $11.8B | $22.7B | $19.3B | $22.8B | $21.2B | $21.1B | $18.2B | $22.5B | $21.4B | $20.4B | $18.9B | $18.5B | $15.4B | $11.4B | $9.3B | $6.7B | $5.9B | $6.4B | $4.3B | $3.8B |
| Shares outstanding | 1.24B | 1.24B | 1.25B | 1.25B | 1.25B | 1.25B | 1.26B | 1.26B | 1.28B | 1.31B | 1.31B | 1.37B | 1.49B | 1.54B | 1.52B | 1.51B | 1.59B | 1.81B | — | — |
| Current ratio | 1.27 | 1.55 | 1.60 | 1.43 | 1.29 | 1.27 | 1.40 | 3.10 | 3.38 | 2.74 | 2.12 | 2.50 | 3.07 | 1.09 | 1.45 | 5.53 | 2.32 | 2.57 | 3.50 | — |